Clinical Trials Logo

Clinical Trial Summary

Developmental dyslexia (DD) is the most common learning disorder. Multiple cognitive and sensory domains contribute to the etiology of DD and develop before reading acquisition. Atypical brain functional responses and structural features have been found in the reading developing circuitry. Treatments addressing visual-spatial attention and motion perception (Visual Attention Training; VAT) are among the most effective interventions in Italian children with DD. The VAT seems to improve the efficiency of the visual attention system and the magnocellular (M) pathway which is crucial for learning to read. Evidence for impaired M function in subjects with DD in the visual striate and extra-striate cortex have been reported. How these treatments affect the brain functionality is still not clear. Since DD has a neurobiological basis, it is important to deeply investigate atypical functional responses and structural features in reading-related areas, and to understand how treatments operate at the neuronal level. A growing number of studies investigates structural and functional measures in neurodevelopmental disorders by using high-resolution MRI at high field (3T and 7T). Similarly, several studies examine the effects of different types of reading training upon brain activity. Better understanding of the relationship between structural/functional abnormalities and DD could disentangle the causes of reading difficulties and helps in developing effective treatments. The significance of this study is twofold: 1) NEURAL CORRELATES OF TREATMENT: The investigators expect TACHIDINO to specifically affect the underlying neurophysiological functioning which influences reading skills in children with DD; 2) BRAIN SIGNATURES: As integrated multi-domain data (behavioral and brain imaging) are complementary to each other, they could enhance the possibility to find unique treatment/brain functioning combinations to evaluate the effectiveness of intervention and to predict the treatment response.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05373576
Study type Interventional
Source IRCCS Eugenio Medea
Contact Sara Mascheretti, PhD
Phone +39031877924
Email sara.mascheretti@lanostrafamiglia.it
Status Recruiting
Phase N/A
Start date January 2, 2022
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT04028310 - Developmental Dyslexia and Remediation Methods N/A
Recruiting NCT04122820 - Ambulatory Screening for Specific Learning Disabilities (SLD) and Developmental Coordination Disorder (DCD). N/A
Recruiting NCT04287530 - Poly-unsaturated Fatty Acids and Developmental Dyslexia N/A
Enrolling by invitation NCT04323488 - Neural Mechanisms of Successful Intervention in Children With Dyslexia N/A
Completed NCT04041960 - Effects of TBS on Reading in Adult Struggling Readers N/A
Recruiting NCT06261307 - Language Development Deficits and Early Interactive Music Intervention N/A
Recruiting NCT06387615 - Impact of Non-invasive Brain Stimulation on Learning Novel Spoken Words N/A
Not yet recruiting NCT06403007 - Tackling Two of the Most Important Unresolved Tasks in Reading Intervention N/A